Versant Venture Capital V (Canada), LP, 10% Owner at CRISPR Therapeutics AG (CRSP), bought 231,679 shares at $14.00 ($8K) on 2016-10-24, disclosed to the SEC on 2016-12-23.
Open-market purchase of $8k CRSP by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 231,077 | $0 | 0.0% |
| 2 | $14.00 | 602 | $8K | 100.0% |
| Total | $0.04 avg | 231,679 | $8K | 100% |